Artificial Heart-lung Machine Market By Type (single Roller Pump, And Double Roller Pump) And By Application (cardiac Surgery, Lung Transplantation Operations, Acute Respiratory Failure Treatment, And Others) - Global Industry Analysis And Forecast To 2023

Published On : June 2022 Pages : 190 Category: Medical Devices Report Code : HC061034

Industry Outlook and Trend Analysis

The Artificial Heart-Lung Machine Market is expected to witness considerable growth during the forecast period.  The artificial heart-lung machine is significantly utilized for open heart surgery to help the right working of the body and heart amid the task. The heart-lung machine for the most part incorporates a chamber that gathers the blood from the body additionally oxygenates it, lastly exchanges it to various parts of the body. This equipment is connected to the patient with a scope of tubes, which is isolated after the finish of the task when the lungs and heart retain its capacities.

Drivers & Restrains

Major factors driving worldwide artificial heart-lung machine market are expanding pervasiveness for heart sicknesses, rising awareness about the distinctive cardiovascular devices accessible and developing government activities in the field. Moreover, mechanical progressions and change in the medicinal services offices are driving the artificial heart-lung machine market. However, less lifecycle of the product is controlling the worldwide artificial heart-lung machine market. Developing demographics and economies in the creating nations hold an extraordinary potential for development of artificial heart-lung machine market. Furthermore, development of artificial heart-lung machines with enhanced highlights and lifecycle are required to offer great open doors for artificial heart-lung machine market. One of the most recent patterns that have been seen in the artificial heart-lung machine market incorporates the organizations associated with research and development of new products with enhanced highlights.

Regional Outlook and Trend Analysis

North America commands the worldwide market for artificial heart-lung machine because of high prevalence of heart issues and maturing populace in the locale. Likewise, innovative progression in the field is driving the artificial heart-lung machine market in North America. Asia, trailed by Europe, is relied upon to indicate high development rate in next couple of years in worldwide artificial heart-lung machine market. China and India are relied upon to be the quickest developing artificial heart-lung machine market in Asian district. Moreover, rising government financing and developing awareness in the field is driving the artificial heart-lung machine market in these locales.

Competitive Insights

The leading players in the market are Medtronic Inc., MAQUET GmbH & Co. KG, Sorin Group, Edwards Lifesciences, Tianjin Medical and others. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

The Artificial Heart-Lung Machine Market is segmented as follows-

By Type:

  • Single Roller Pump
  • Double Roller Pump

By Application:

  • Cardiac Surgery
  • Lung Transplantation Operations
  • Acute Respiratory Failure Treatment
  • Other Applications

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Southeast Asia
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Columbia
    • South Africa
    • Rest of South America
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Nigeria
    • South Africa
    • Rest of MEA

Some of the key questions answered by the report are:

  • What was the market size in 2017 and forecast from 2017 to 2023?
  • What will be the industry market growth from 2017 to 2023?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

·         Artificial Heart-Lung Machine Market, By Type, Estimates and Forecast, 2014-2023 ($Million)

·         Single Roller Pump

·         Double Roller Pump

·         Artificial Heart-Lung Machine Market, By Application, Estimates and Forecast, 2014-2023 ($Million)

·         Cardiac Surgery

·         Lung Transplantation Operations

·         Acute Respiratory Failure Treatment

·         Other Applications

·         Artificial Heart-Lung Machine Market, By Region, Estimates and Forecast, 2014-2023 ($Million)

·         North America

§  North America Artificial Heart-Lung Machine Market, By Country

o    U.S. Artificial Heart-Lung Machine Market

o    Canada Artificial Heart-Lung Machine Market

o    Mexico Artificial Heart-Lung Machine Market

·         Europe

§  Europe Artificial Heart-Lung Machine Market, By Country

o    Germany Artificial Heart-Lung Machine Market

o    UK Artificial Heart-Lung Machine Market

o    France Artificial Heart-Lung Machine Market

o    Russia Artificial Heart-Lung Machine Market

o    Italy Artificial Heart-Lung Machine Market

o    Rest of Europe Artificial Heart-Lung Machine Market

·         Asia-Pacific

§  Asia-Pacific Artificial Heart-Lung Machine Market, By Country

o    China Artificial Heart-Lung Machine Market

o    Japan Artificial Heart-Lung Machine Market

o    South Korea Artificial Heart-Lung Machine Market

o    India Artificial Heart-Lung Machine Market

o    Southeast Asia Artificial Heart-Lung Machine Market

o    Rest of Asia-Pacific Artificial Heart-Lung Machine Market

·         South America

§  South America Artificial Heart-Lung Machine Market

o    Brazil Artificial Heart-Lung Machine Market

o    Argentina Artificial Heart-Lung Machine Market

o    Columbia Artificial Heart-Lung Machine Market

o    South Africa Artificial Heart-Lung Machine Market

o    Rest of South America Artificial Heart-Lung Machine Market

·         Middle East and Africa

§  Middle East and Africa Artificial Heart-Lung Machine Market

o    Saudi Arabia Artificial Heart-Lung Machine Market

o    UAE Artificial Heart-Lung Machine Market

o    Egypt Artificial Heart-Lung Machine Market

o    Nigeria Artificial Heart-Lung Machine Market

o    South Africa Artificial Heart-Lung Machine Market

o    Rest of MEA Artificial Heart-Lung Machine Market

Table of Contents

1.       Introduction

1.1.       Report Description

1.2.       Research Methodology

1.2.1.  Secondary Research

1.2.2.  Primary Research

2.       Executive Summary

2.1.       Key Highlights

3.       Market Overview

3.1.       Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.       Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

3.2.3.1.    Emerging Markets to Offer Lucrative Growth Opportunities

4.       Market Analysis by Regions

4.1.       North America (United States, Canada and Mexico)

4.1.1.  United States Market States and Outlook (2017-2023)

4.1.2.  Canada Market States and Outlook (2017-2023)

4.1.3.  Mexico Market States and Outlook (2017-2023)

4.2.       Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market States and Outlook (2017-2023)

4.2.2.  France Market States and Outlook (2017-2023)

4.2.3.  UK Market States and Outlook (2017-2023)

4.2.4.  Russia Market States and Outlook (2017-2023)

4.2.5.  Italy Market States and Outlook (2017-2023)

4.2.6.  Rest of Europe Market States and Outlook (2017-2023)

4.3.       Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market States and Outlook (2017-2023)

4.3.2.  Japan Market States and Outlook (2017-2023)

4.3.3.  Korea Market States and Outlook (2017-2023)

4.3.4.  India Market States and Outlook (2017-2023)

4.3.5.  Rest of Asia-Pacific Market States and Outlook (2017-2023)

4.4.       South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market States and Outlook (2017-2023)

4.4.2.  Argentina Market States and Outlook (2017-2023)

4.4.3.  Columbia Market States and Outlook (2017-2023)

4.4.4.  Rest of South America Market States and Outlook (2017-2023)

4.5.       Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market States and Outlook (2017-2023)

4.5.2.  UAE Market States and Outlook (2017-2023)

4.5.3.  Egypt Market States and Outlook (2017-2023)

4.5.4.  Nigeria Market States and Outlook (2017-2023)

4.5.5.  South Africa Market States and Outlook (2017-2023)

4.5.6.  Rest of MEA Market States and Outlook (2017-2023)

5.       Artificial Heart-Lung Machine Market, By Type

5.1.       Introduction

5.2.       Global Artificial Heart-Lung Machine Sales, Revenue and Market Share by Type (2017-2027)

5.2.1.  Global Artificial Heart-Lung Machine Sales and Sales Share by Type (2017-2027)

5.2.2.  Global Artificial Heart-Lung Machine Revenue and Revenue Share by Type (2017-2027)

5.3.       Single Roller Pump

5.3.1.  Global Single Roller Pump Sales and Growth Rate (2017-2027)

5.4.       Double Roller Pump

5.4.1.  Global Double Roller Pump Sales and Growth Rate (2017-2027)

6.       Artificial Heart-Lung Machine Market, By Application

6.1.       Introduction

6.2.       Global Artificial Heart-Lung Machine Sales, Revenue and Market Share by Application (2017-2027)

6.2.1.  Global Artificial Heart-Lung Machine Sales and Sales Share by Application (2017-2027)

6.2.2.  Global Artificial Heart-Lung Machine Revenue and Revenue Share by Application (2017-2027)

6.3.       Cardiac Surgery

6.3.1.  Global Cardiac Surgery Sales and Growth Rate (2017-2027)

6.4.       Lung Transplantation Operations

6.4.1.  Global Lung Transplantation Operations Sales and Growth Rate (2017-2027)

6.5.       Acute Respiratory Failure Treatment

6.5.1.  Global Acute Respiratory Failure Treatment Sales and Growth Rate (2017-2027)

6.6.       Other Applications

6.6.1.  Global Other Applications Sales and Growth Rate (2017-2027)

7.       Artificial Heart-Lung Machine Market, By Region

7.1.       Introduction

7.2.       Global Artificial Heart-Lung Machine Sales, Revenue and Market Share by Regions

7.2.1.  Global Artificial Heart-Lung Machine Sales by Regions (2017-2027)

7.2.2.  Global Artificial Heart-Lung Machine Revenue by Regions (2017-2027)

7.3.       North America Artificial Heart-Lung Machine by Countries

7.3.1.  North America Artificial Heart-Lung Machine Sales and Growth Rate (2017-2027)

7.3.2.  North America Artificial Heart-Lung Machine Revenue and Growth Rate (2017-2027)

7.3.3.  North America Artificial Heart-Lung Machine Sales by Countries (2017-2027)

7.3.4.  North America Artificial Heart-Lung Machine Revenue (Million USD) by Countries (2017-2027)

7.3.5.  U.S.

7.3.5.1.    United States Artificial Heart-Lung Machine Sales and Growth Rate (2017-2027)

7.3.5.2.    United States Artificial Heart-Lung Machine Revenue (Millions USD) and Growth Rate (2017-2027)

7.3.6.  Canada

7.3.6.1.    Canada Artificial Heart-Lung Machine Sales and Growth Rate (2017-2027)

7.3.6.2.    Canada Artificial Heart-Lung Machine Sales (Millions USD) and Growth Rate (2017-2027)

7.3.7.  Mexico

7.3.7.1.    Mexico Artificial Heart-Lung Machine Sales and Growth Rate (2017-2027)

7.3.7.2.    Mexico Artificial Heart-Lung Machine Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.       Europe Artificial Heart-Lung Machine by Countries

7.4.1.  Europe Artificial Heart-Lung Machine Sales and Growth Rate (2017-2027)

7.4.2.  Europe Artificial Heart-Lung Machine Revenue and Growth Rate (2017-2027)

7.4.3.  Europe Artificial Heart-Lung Machine Sales by Countries (2017-2027)

7.4.4.  Europe Artificial Heart-Lung Machine Revenue (Million USD) by Countries (2017-2027)

7.4.5.  Germany

7.4.5.1.    Germany Artificial Heart-Lung Machine Sales and Growth Rate (2017-2027)

7.4.5.2.    Germany Artificial Heart-Lung Machine Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.6.  UK

7.4.6.1.    UK Artificial Heart-Lung Machine Sales and Growth Rate (2017-2027)

7.4.6.2.    UK Artificial Heart-Lung Machine Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.7.  France

7.4.7.1.    France Artificial Heart-Lung Machine Sales and Growth Rate (2017-2027)

7.4.7.2.    France Artificial Heart-Lung Machine Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.8.  Russia

7.4.8.1.    Russia Artificial Heart-Lung Machine Sales and Growth Rate (2017-2027)

7.4.8.2.    Russia Artificial Heart-Lung Machine Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.9.  Italy

7.4.9.1.    Italy Artificial Heart-Lung Machine Sales and Growth Rate (2017-2027)

7.4.9.2.    Italy Artificial Heart-Lung Machine Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.10.      Rest of Europe

7.4.10.1. Rest of Europe Artificial Heart-Lung Machine Sales and Growth Rate (2017-2027)

7.4.10.2. Rest of Europe Artificial Heart-Lung Machine Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.       Asia-Pacific

7.5.1.  Asia-Pacific Artificial Heart-Lung Machine Sales and Growth Rate (2017-2027)

7.5.2.  Asia-Pacific Artificial Heart-Lung Machine Revenue and Growth Rate (2017-2027)

7.5.3.  Asia-Pacific Artificial Heart-Lung Machine Sales by Countries (2017-2027)

7.5.4.  Asia-Pacific Artificial Heart-Lung Machine Revenue (Million USD) by Countries (2017-2027)

7.5.5.  China

7.5.5.1.    China Artificial Heart-Lung Machine Sales and Growth Rate (2017-2027)

7.5.5.2.    China Artificial Heart-Lung Machine Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.6.  Japan

7.5.6.1.    Japan Artificial Heart-Lung Machine Sales and Growth Rate (2017-2027)

7.5.6.2.    Japan Artificial Heart-Lung Machine Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.6.3.     

7.5.7.  Korea

7.5.7.1.    Korea Artificial Heart-Lung Machine Sales and Growth Rate (2017-2027)

7.5.7.2.    Korea Artificial Heart-Lung Machine Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.8.  India

7.5.8.1.    India Artificial Heart-Lung Machine Sales and Growth Rate (2017-2027)

7.5.8.2.    India Artificial Heart-Lung Machine Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.9.  Southeast Asia

7.5.9.1.    Southeast Asia Artificial Heart-Lung Machine Sales and Growth Rate (2017-2027)

7.5.9.2.    Southeast Asia Artificial Heart-Lung Machine Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.10.      Rest of Asia-Pacific

7.5.10.1. Rest of Asia-Pacific Artificial Heart-Lung Machine Sales and Growth Rate (2017-2027)

7.5.10.2. Rest of Asia-Pacific Artificial Heart-Lung Machine Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.       South America

7.6.1.  South America Artificial Heart-Lung Machine Sales and Growth Rate (2017-2027)

7.6.2.  South America Artificial Heart-Lung Machine Revenue and Growth Rate (2017-2027)

7.6.3.  South America Artificial Heart-Lung Machine Sales by Countries (2017-2027)

7.6.4.  South America Artificial Heart-Lung Machine Revenue (Million USD) by Countries (2017-2027)

7.6.5.  Brazil

7.6.5.1.    Brazil Artificial Heart-Lung Machine Sales and Growth Rate (2017-2027)

7.6.5.2.    Brazil Artificial Heart-Lung Machine Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.6.  Argentina

7.6.6.1.    Argentina Artificial Heart-Lung Machine Sales and Growth Rate (2017-2027)

7.6.6.2.    Argentina Artificial Heart-Lung Machine Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.7.  Columbia

7.6.7.1.    Columbia Artificial Heart-Lung Machine Sales and Growth Rate (2017-2027)

7.6.7.2.    Columbia Artificial Heart-Lung Machine Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.8.  Rest of South America

7.6.8.1.    Rest of South America Artificial Heart-Lung Machine Sales and Growth Rate (2017-2027)

7.6.8.2.    Rest of South America Artificial Heart-Lung Machine Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.       Middle East and Africa

7.7.1.  Middle East and Africa Artificial Heart-Lung Machine Sales and Growth Rate (2017-2027)

7.7.2.  Middle East and Africa Artificial Heart-Lung Machine Revenue and Growth Rate (2017-2027)

7.7.3.  Middle East and Africa Artificial Heart-Lung Machine Sales by Countries (2017-2027)

7.7.4.  Middle East and Africa Artificial Heart-Lung Machine Revenue (Million USD) by Countries (2017-2027)

7.7.5.  Saudi Arabia

7.7.5.1.    Saudi Arabia Artificial Heart-Lung Machine Sales and Growth Rate (2017-2027)

7.7.5.2.    Saudi Arabia Artificial Heart-Lung Machine Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.6.  United Arab Emirates

7.7.6.1.    United Arab Emirates Artificial Heart-Lung Machine Sales and Growth Rate (2017-2027)

7.7.6.2.    United Arab Emirates Artificial Heart-Lung Machine Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.7.  Egypt

7.7.7.1.    Egypt Artificial Heart-Lung Machine Sales and Growth Rate (2017-2027)

7.7.7.2.    Egypt Artificial Heart-Lung Machine Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.8.  Nigeria

7.7.8.1.    Nigeria Artificial Heart-Lung Machine Sales and Growth Rate (2017-2027)

7.7.8.2.    Nigeria Artificial Heart-Lung Machine Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.9.  South Africa

7.7.9.1.    South Africa Artificial Heart-Lung Machine Sales and Growth Rate (2017-2027)

7.7.9.2.    South Africa Artificial Heart-Lung Machine Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.10.      Rest of Middle East and Africa

7.7.10.1. Rest of Middle East and Africa Artificial Heart-Lung Machine Sales and Growth Rate (2017-2027)

7.7.10.2. Rest of Middle East and Africa Artificial Heart-Lung Machine Revenue (Millions USD) and Growth Rate (2017-2027)

8.       Company Profiles

8.1.       Medtronic Inc.

8.1.1.  Business Overview

8.1.2.  Product Portfolio

8.1.3.  Strategic Developments

8.1.4.  Sales, Revenue and Market Share

8.2.       Sorin Group

8.2.1.  Business Overview

8.2.2.  Product Portfolio

8.2.3.  Strategic Developments

8.2.4.  Sales, Revenue and Market Share

8.3.       MAQUET GmbH & Co. KG

8.3.1.  Business Overview

8.3.2.  Product Portfolio

8.3.3.  Strategic Developments

8.3.4.  Sales, Revenue and Market Share

8.4.       Terumo Corporation

8.4.1.  Business Overview

8.4.2.  Product Portfolio

8.4.3.  Strategic Developments

8.4.4.  Sales, Revenue and Market Share

8.5.       C. R. Bard Inc.

8.5.1.  Business Overview

8.5.2.  Product Portfolio

8.5.3.  Strategic Developments

8.5.4.  Sales, Revenue and Market Share

8.6.       Edwards Lifesciences

8.6.1.  Business Overview

8.6.2.  Product Portfolio

8.6.3.  Strategic Developments

8.6.4.  Sales, Revenue and Market Share

8.7.       Braile Biomedica

8.7.1.  Business Overview

8.7.2.  Product Portfolio

8.7.3.  Strategic Developments

8.7.4.  Sales, Revenue and Market Share

8.8.       Tianjin Medical

8.8.1.  Business Overview

8.8.2.  Product Portfolio

8.8.3.  Strategic Developments

8.8.4.  Sales, Revenue and Market Share

8.9.       SynCardia

8.9.1.  Business Overview

8.9.2.  Product Portfolio

8.9.3.  Strategic Developments

8.9.4.  Sales, Revenue and Market Share

8.10.    Jarvik Heart

8.10.1.      Business Overview

8.10.2.      Product Portfolio

8.10.3.      Strategic Developments

8.10.4.      Sales, Revenue and Market Share

9.       Global Artificial Heart-Lung Machine Market Competition, by Manufacturer

9.1.       Global Artificial Heart-Lung Machine Sales and Market Share by Manufacturer (2017-2017)

9.2.       Global Artificial Heart-Lung Machine Revenue and Market Share by Manufacturer (2017-2017)

9.3.       Global Artificial Heart-Lung Machine Price by Manufacturer (2017-2017)

9.4.       Top 5 Artificial Heart-Lung Machine Manufacturer Market Share

9.5.       Market Competition Trend

10.   Artificial Heart-Lung Machine Market Forecast (2027-2023)

10.1.    Global Artificial Heart-Lung Machine Sales, Revenue (Millions USD) and Growth Rate (2027-2023)

10.2.    Artificial Heart-Lung Machine Market Forecast by Regions (2027-2023)

10.2.1.      North America Artificial Heart-Lung Machine Market Forecast (2027-2023)

10.2.1.1. United States Artificial Heart-Lung Machine Market Forecast (2027-2023)

10.2.1.2. Canada Artificial Heart-Lung Machine Market Forecast (2027-2023)

10.2.1.3. Mexico Artificial Heart-Lung Machine Market Forecast (2027-2023)

10.2.2.      Europe Artificial Heart-Lung Machine Market Forecast (2027-2023)

10.2.2.1. Germany Artificial Heart-Lung Machine Market Forecast (2027-2023)

10.2.2.2. United Kingdom Artificial Heart-Lung Machine Market Forecast (2027-2023)

10.2.2.3. France Artificial Heart-Lung Machine Market Forecast (2027-2023)

10.2.2.4. Russia Artificial Heart-Lung Machine Market Forecast (2027-2023)

10.2.2.5. Italy Artificial Heart-Lung Machine Market Forecast (2027-2023)

10.2.2.6. Rest of the Europe Artificial Heart-Lung Machine Market Forecast (2027-2023)

10.2.3.      Asia-Pacific Artificial Heart-Lung Machine Market Forecast (2027-2023)

10.2.3.1. China Artificial Heart-Lung Machine Market Forecast (2027-2023)

10.2.3.2. Japan Artificial Heart-Lung Machine Market Forecast (2027-2023)

10.2.3.3. Korea Artificial Heart-Lung Machine Market Forecast (2027-2023)

10.2.3.4. India Artificial Heart-Lung Machine Market Forecast (2027-2023)

10.2.3.5. Southeast Asia Artificial Heart-Lung Machine Market Forecast (2027-2023)

10.2.3.6. Rest of Asia-Pacific Artificial Heart-Lung Machine Market Forecast (2027-2023)

10.2.4.      South America Artificial Heart-Lung Machine Market Forecast (2027-2023)

10.2.4.1. Brazil Artificial Heart-Lung Machine Market Forecast (2027-2023)

10.2.4.2. Argentina Artificial Heart-Lung Machine Market Forecast (2027-2023)

10.2.4.3. Columbia Artificial Heart-Lung Machine Market Forecast (2027-2023)

10.2.4.4. Rest of South America Artificial Heart-Lung Machine Market Forecast (2027-2023)

10.2.5.      Middle East and Africa Artificial Heart-Lung Machine Market Forecast (2027-2023)

10.2.5.1. Saudi Arabia Artificial Heart-Lung Machine Market Forecast (2027-2023)

10.2.5.2. UAE Artificial Heart-Lung Machine Market Forecast (2027-2023)

10.2.5.3. Egypt Artificial Heart-Lung Machine Market Forecast (2027-2023)

10.2.5.4. Nigeria Artificial Heart-Lung Machine Market Forecast (2027-2023)

10.2.5.5. South Africa Artificial Heart-Lung Machine Market Forecast (2027-2023)

10.2.5.6. Rest of MEA Artificial Heart-Lung Machine Market Forecast (2027-2023)

10.3.    Artificial Heart-Lung Machine Market Forecast by Type (2027-2023)

10.3.1.      Global Artificial Heart-Lung Machine Sales Forecast by Type (2027-2023)

10.3.2.      Global Artificial Heart-Lung Machine Sales Market Share Forecast by Type (2027-2023)

10.4.    Artificial Heart-Lung Machine Market Forecast by Application (2027-2023)

10.4.1.      Global Artificial Heart-Lung Machine Sales Forecast by Application (2027-2023)

10.4.2.      Global Artificial Heart-Lung Machine Sales Market Share Forecast by Application (2027-2023)


List of Tables

*You can glance through the list of Tables and Figures when you view the sample copy of Artificial Heart-Lung Machine Market.


Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*